Avidity Biosciences (RNA) Receivables (2022 - 2024)
Historic Receivables for Avidity Biosciences (RNA) over the last 3 years, with Q4 2024 value amounting to $9.4 million.
- Avidity Biosciences' Receivables rose 75493.21% to $9.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $9.4 million, marking a year-over-year increase of 75493.21%. This contributed to the annual value of $9.4 million for FY2024, which is 75493.21% up from last year.
- Latest data reveals that Avidity Biosciences reported Receivables of $9.4 million as of Q4 2024, which was up 75493.21% from $1.6 million recorded in Q1 2024.
- Avidity Biosciences' 5-year Receivables high stood at $9.4 million for Q4 2024, and its period low was $1.1 million during Q4 2023.
- In the last 3 years, Avidity Biosciences' Receivables had a median value of $1.6 million in 2024 and averaged $3.1 million.
- Per our database at Business Quant, Avidity Biosciences' Receivables plummeted by 5325.72% in 2023 and then surged by 75493.21% in 2024.
- Avidity Biosciences' Receivables (Quarter) stood at $2.4 million in 2022, then tumbled by 53.26% to $1.1 million in 2023, then surged by 754.93% to $9.4 million in 2024.
- Its last three reported values are $9.4 million in Q4 2024, $1.6 million for Q1 2024, and $1.1 million during Q4 2023.